BPG is committed to discovery and dissemination of knowledge
Editorial
Copyright: ©Author(s) 2026.
World J Gastrointest Endosc. Aug 16, 2026; 18(8): 121774
Published online Aug 16, 2026. doi: 10.4253/wjge.121774
Table 1 Key controversies and evidence gaps in bleeding prevention after colorectal endoscopic resection
Clinical issue
What current evidence supports
What remains uncertain
Cold vs hot resection for 10-19 mm nonpedunculated lesionsCold resection reduces thermal injury and delayed bleeding, but current guidelines are not fully aligned: ESGE 2024 favors hot snare polypectomy for 10-19 mm nonpedunculated adenomatous polyps, whereas USMSTF 2020 permits either cold or hot snare resection in this size rangeWhether the bleeding advantage of cold resection is sufficient to outweigh concerns regarding complete excision, margin negativity, and histologic adequacy in adenomatous lesions remains unresolved
Whether cold EMR should expand to lesions ≥ 20 mmCold EMR appears to have a favorable safety profile in selected lesions, particularly sessile serrated lesions without suspected dysplasia. ESGE 2024 supports piecemeal CSP or cold EMR for SSLs of any size without suspected dysplasia, while reserving cold piecemeal resection of large flat adenomatous lesions for selected situationsWhether this safety advantage justifies broader use in large adenomatous lesions despite higher residual or recurrent neoplasia
Prophylactic clipping after EMRESGE 2024 recommends clip closure after conventional EMR of large nonpedunculated lesions in the right colon but suggests against routine clipping for lesions < 20 mm and for ≥ 20 mm lesions in the left colonWhich lesions outside this clearly high-risk subgroup derive meaningful benefit from closure remains uncertain, particularly with respect to intermediate-sized lesions, left-sided lesions, and varying antithrombotic risk
Routine vs selective closure after colorectal ESDRecent studies and meta-analyses suggest that prophylactic closure after colorectal ESD may reduce CSDB, although the evidence remains heterogeneousWhether routine closure is justified remains unclear, because the balance of benefit, feasibility, procedure time, cost, lesion size, location, and antithrombotic exposure varies substantially across studies and practice settings


Write to the Help Desk